Literature DB >> 18057351

Growth of a meningioma in a transsexual patient after estrogen-progestin therapy.

Roberto Gazzeri, Marcelo Galarza, Giovanni Gazzeri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18057351     DOI： 10.1056/NEJMc071938

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  21 in total

Review 1.  Cancer in Transgender People: Evidence and Methodological Considerations.

Authors:  Hayley Braun; Rebecca Nash; Vin Tangpricha; Janice Brockman; Kevin Ward; Michael Goodman
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

2.  Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience.

Authors:  Thomas Samoyeau; Marc Zanello; Alexandre Roux; Joseph Benzakoun; Henri Malaize; Sophie Peeters; Gilles Zah-Bi; Myriam Edjlali; Arnault Tauziede-Espariat; Edouard Dezamis; Eduardo Parraga; Fabrice Chrétien; Pascale Varlet; Geneviève Plu-Bureau; Catherine Oppenheim; Johan Pallud
Journal:  J Neurooncol       Date:  2021-01-15       Impact factor: 4.130

3.  Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma.

Authors:  Edouard Samarut; Alexandre Lugat; Aymeric Amelot; Emeric Scharbarg; Samy Hadjadj; Claire Primot; Delphine Loussouarn; François Thillays; Kevin Buffenoir; Bertrand Cariou; Delphine Drui; Vincent Roualdes
Journal:  J Neurooncol       Date:  2021-01-03       Impact factor: 4.130

4.  The relationship between urinary bisphenol A levels and meningioma in Chinese adults.

Authors:  Bo Duan; Xuebin Hu; Hongyang Zhao; Jun Qin; Jie Luo
Journal:  Int J Clin Oncol       Date:  2012-04-25       Impact factor: 3.402

5.  Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.

Authors:  Dominique S Michaud; Valentina Gallo; Brigitte Schlehofer; Anne Tjønneland; Anja Olsen; Kim Overvad; Christina C Dahm; Rudolf Kaaks; Annekatrin Lukanova; Heiner Boeing; Madlen Schütze; Antonia Trichopoulou; Christina Bamia; Andreas Kyrozis; Carlotta Sacerdote; Claudia Agnoli; Domenico Palli; Rosario Tumino; Amalia Mattiello; H Bas Bueno-de-Mesquita; Martine M Ros; Petra H M Peeters; Carla H van Gils; Eiliv Lund; Kjersti Bakken; Inger T Gram; Aurelio Barricarte; Carmen Navarro; Miren Dorronsoro; Maria José Sánchez; Laudina Rodríguez; Eric J Duell; Göran Hallmans; Beatrice S Melin; Jonas Manjer; Signe Borgquist; Kay-Tee Khaw; Nick Wareham; Naomi E Allen; Konstantinos K Tsilidis; Isabelle Romieu; Sabina Rinaldi; Paolo Vineis; Elio Riboli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-27       Impact factor: 4.254

Review 6.  Medical therapies for meningiomas.

Authors:  Patrick Y Wen; Eudocia Quant; Jan Drappatz; Rameen Beroukhim; Andrew D Norden
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

Review 7.  Oestrogen and anti-androgen therapy for transgender women.

Authors:  Vin Tangpricha; Martin den Heijer
Journal:  Lancet Diabetes Endocrinol       Date:  2016-12-02       Impact factor: 32.069

8.  Abrupt regression of a meningioma after discontinuation of cyproterone treatment.

Authors:  A M G Gonçalves; P Page; V Domigo; J-F Méder; C Oppenheim
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-06       Impact factor: 3.825

Review 9.  Medical management of meningiomas.

Authors:  Wendy J Sherman; Jeff J Raizer
Journal:  CNS Oncol       Date:  2013-03

Review 10.  Advances in meningioma therapy.

Authors:  Andrew D Norden; Jan Drappatz; Patrick Y Wen
Journal:  Curr Neurol Neurosci Rep       Date:  2009-05       Impact factor: 5.081
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.